Research News for June 2008
11–11 of 11 articles
-
Adding Tykerb to Herceptin Helps if Metastatic Breast Cancer Grows
Women diagnosed with HER2-positive metastatic breast cancer that either came back or progressed while getting Herceptin (chemical name: tastuzumab) benefited from adding Tykerb (chemical name: lapatanib) to the treatment plan instead of switching from Herceptin to Tykerb.
11–11 of 11 articles
